TickerFactsScreenerDevelopers

Forte Biosciences, Inc. (FBRX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$29.54M2017: -$31.13M2018: -$34.47M2019: -$2.77M2020: -$18.42M2021: -$16.68M2022: -$8.19M2023: -$28.71M2024: -$30.75M2025: -$50.88M-$50.88M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$50.88M-65.5%
2024-$30.75M-7.1%
2023-$28.71M-250.7%
2022-$8.19M+50.9%
2021-$16.68M+9.5%
2020-$18.42M-564.9%
2019-$2.77M+92.0%
2018-$34.47M-10.7%
2017-$31.13M-5.4%
2016-$29.54M—